Search Results 211-220 of 16906 for lamotrigine
This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...
About this study. The purpose of this study is to define the maximum tolerated dose of AC220 when combined with induction and consolidation therapy and as ...
Current treatment includes any medication known to affect the N‐methyl‐D‐aspartate receptor system (e.g., lamotrigine, acamprosate, memantine, riluzole, or ...
The purpose of this study is to evaluate the safety and to determine the recommended phase 2 dose (RP2D) of Lutetium Lu 177 Dotatate in combination with ...
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest and can interfere with your daily functioning.
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
They include magnetic resonance imaging, subtraction ictal SPECT coregistered to MRI (SISCOM), electroencephalography, ketogenic diet, deep brain stimulation, ...
Your healthcare professional may suspect narcolepsy based on your symptoms of daytime sleepiness and sudden loss of muscle tone, known as cataplexy. Your ...
This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule, Extended Release. Back to top ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!